Joon-Kee Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joon-Kee Park has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Yang-Jin Park
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
4 shared publications - Dong-Ik Kim
Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications - Shin-Seok Yang
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications - Da-Hyun Kim
Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications Dong-Ik Kim
Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications- Hyo-Shin Kim
Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 42, 13
Cephalic Vein Aneurysm of the Wrist Adjacent to the Superficial Radial Nerve: A Case Report
Hee Gyun Yang, Joon-Kee Park, and Yang-Jin Park. Vasc Specialist Int 2026;42:. https://doi.org/10.5758/vsi.250154
- 19 March 2026
- Published by The Korean Society for Vascular Surgery in Vascular Specialist International
- Vol. 42, 13
Open AccessCephalic Vein Aneurysm of the Wrist Adjacent to the Superficial Radial Nerve: A Case Report
Hee Gyun Yang, Joon-Kee Park, and Yang-Jin Park. Vasc Specialist Int 2026;42:. https://doi.org/10.5758/vsi.250154
- Open Access
- 17 March 2025
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 18 (3) , 254-262
A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia
Yong-Man Park, Joon-Kee Park, Hyo-Shin Kim, Shin-Seok Yang, Jong-Wan Kim, Dong-Ik Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc25002
- 17 March 2025
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 18 (3) , 254-262
Open AccessA Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia
Yong-Man Park, Joon-Kee Park, Hyo-Shin Kim, Shin-Seok Yang, Jong-Wan Kim, Dong-Ik Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc25002
- 8 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (4) , 796-802
Fate assessment of the ectatic common iliac artery using flared limb during endovascular aneurysm repair
Objectives: This study aimed to evaluate the outcomes and anatomical predictors of the complications of flared limb (FL) use for ectatic common iliac arteries accompanied by abdominal aortic aneurysm treated with endovascular aneurysm repair (EVAR). Methods: In this single-center retrospective study, we reviewed data from 391 patients (638 limbs) treated between 2005 and 2020. The cohort was divided into two groups. The standard limbs (SLs, n = 403) included stent graft (SG) of n = 235) included stent graft of ≥20 mm in diameter. Complications within 30 days were investigated as the short-term outcome. Limb events during follow-up including type Ib endoleak (EL), type IIIa EL, and limb occlusion were compared between SLs and FLs using log-rank test. Results: Early results indicated that the FL group had a significantly higher incidence of intraoperative type Ib EL at 5.1% (12), than 1.7% (7) in the SLs ( p = .016). For 19 patients in whom intraoperative type Ib EL was discovered, SG extension alone or internal iliac artery embolization was all performed before completing the procedure. Overall, we noted one case of type Ib EL and two cases of limb events in each group at 30 days. Over a median follow-up of 39 months, 31 (4.9%) events (17 type Ib EL, 2 type IIIa EL, and 12 limb events), 13 (5.5%) in FLs and 18 (4.5%) in SLs ( p = .984), were observed. The FLs had significantly higher rates of aortic sac enlargement, with 46 (19.6%) cases for FLs and 36 (8.9%) for SLs ( p < .001). The Kaplan–Meier analysis revealed significant differences at 5 years in SLs versus FLs for freedom from type Ib EL (96.6% vs 82.4%, respectively; p < .001) and no difference in freedom from limb events (94.7% vs 84.5%, respectively; p = .519). Furthermore, no difference was observed for overall survival and aneurysm-related mortality. Conclusions: Although an FL for EVAR is used to treat dilated iliac arteries, there is an increased risk of intraoperative and late type Ib EL and aortic sac enlargement. Long-term close follow-up is mandatory, especially in the patients who undergo EVAR using FLs.
- 8 August 2024
- Published by SAGE Publications in Vascular
- Vol. 33 (4) , 796-802
Fate assessment of the ectatic common iliac artery using flared limb during endovascular aneurysm repair
Objectives: This study aimed to evaluate the outcomes and anatomical predictors of the complications of flared limb (FL) use for ectatic common iliac arteries accompanied by abdominal aortic aneurysm treated with endovascular aneurysm repair (EVAR). Methods: In this single-center retrospective study, we reviewed data from 391 patients (638 limbs) treated between 2005 and 2020. The cohort was divided into two groups. The standard limbs (SLs, n = 403) included stent graft (SG) of n = 235) included stent graft of ≥20 mm in diameter. Complications within 30 days were investigated as the short-term outcome. Limb events during follow-up including type Ib endoleak (EL), type IIIa EL, and limb occlusion were compared between SLs and FLs using log-rank test. Results: Early results indicated that the FL group had a significantly higher incidence of intraoperative type Ib EL at 5.1% (12), than 1.7% (7) in the SLs ( p = .016). For 19 patients in whom intraoperative type Ib EL was discovered, SG extension alone or internal iliac artery embolization was all performed before completing the procedure. Overall, we noted one case of type Ib EL and two cases of limb events in each group at 30 days. Over a median follow-up of 39 months, 31 (4.9%) events (17 type Ib EL, 2 type IIIa EL, and 12 limb events), 13 (5.5%) in FLs and 18 (4.5%) in SLs ( p = .984), were observed. The FLs had significantly higher rates of aortic sac enlargement, with 46 (19.6%) cases for FLs and 36 (8.9%) for SLs ( p < .001). The Kaplan–Meier analysis revealed significant differences at 5 years in SLs versus FLs for freedom from type Ib EL (96.6% vs 82.4%, respectively; p < .001) and no difference in freedom from limb events (94.7% vs 84.5%, respectively; p = .519). Furthermore, no difference was observed for overall survival and aneurysm-related mortality. Conclusions: Although an FL for EVAR is used to treat dilated iliac arteries, there is an increased risk of intraoperative and late type Ib EL and aortic sac enlargement. Long-term close follow-up is mandatory, especially in the patients who undergo EVAR using FLs.
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 107 (6) , 315-326
Validation of the Vascular Study Group of New England (VSGNE) risk prediction model for abdominal aortic aneurysm repair in Korea: a single-center retrospective study
Purpose: The Vascular Study Group of New England (VSGNE) risk prediction model is a simple method for estimating risk for elective abdominal aortic aneurysm (AAA) repair. The model considers both treatment methods and the physical characteristics of the aneurysm type as well as comorbidities. This research aimed to validate its effectiveness by analyzing retrospective data on Korean patients. Methods: Our single-center retrospective analysis included 1,227 patients who underwent elective open repair surgery (ORS) or endovascular aortic repair (EVAR) from 2005 to 2021. We assessed the discrimination of the risk score and the effects of several risk factors. Results: Most patients (66.7%) were classified as low risk in the model, with only 5.6% considered high risk. The mean risk score was 2.81, significantly lower than reported in previous studies. The actual 30-day mortality was only 0.7%, less than the predicted 1.1%. The accuracy of the model in predicting 30-day mortality was statistically significant (area under the curve, 0.822). Patients with high scores were associated with significantly increased mortality (odds ratio, 3.9; P < 0.001). Factors such as advanced age, cerebrovascular disease, and elevated creatinine levels were influential in mortality outcomes. However, a significant difference was not found in short-term mortality between ORS and EVAR. Conclusion: Although the VSGNE model is an objective tool for assessing death risk in elective AAA repair, the actual risk scores in our patient population were lowerthan predicted. To create a more representative tool forthe Korean population, we suggest developing a novel model based on multicenter data collection. [Ann Surg Treat Res 2024;107(6):315-326]
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 107 (6) , 315-326
Open AccessValidation of the Vascular Study Group of New England (VSGNE) risk prediction model for abdominal aortic aneurysm repair in Korea: a single-center retrospective study
Purpose: The Vascular Study Group of New England (VSGNE) risk prediction model is a simple method for estimating risk for elective abdominal aortic aneurysm (AAA) repair. The model considers both treatment methods and the physical characteristics of the aneurysm type as well as comorbidities. This research aimed to validate its effectiveness by analyzing retrospective data on Korean patients. Methods: Our single-center retrospective analysis included 1,227 patients who underwent elective open repair surgery (ORS) or endovascular aortic repair (EVAR) from 2005 to 2021. We assessed the discrimination of the risk score and the effects of several risk factors. Results: Most patients (66.7%) were classified as low risk in the model, with only 5.6% considered high risk. The mean risk score was 2.81, significantly lower than reported in previous studies. The actual 30-day mortality was only 0.7%, less than the predicted 1.1%. The accuracy of the model in predicting 30-day mortality was statistically significant (area under the curve, 0.822). Patients with high scores were associated with significantly increased mortality (odds ratio, 3.9; P < 0.001). Factors such as advanced age, cerebrovascular disease, and elevated creatinine levels were influential in mortality outcomes. However, a significant difference was not found in short-term mortality between ORS and EVAR. Conclusion: Although the VSGNE model is an objective tool for assessing death risk in elective AAA repair, the actual risk scores in our patient population were lowerthan predicted. To create a more representative tool forthe Korean population, we suggest developing a novel model based on multicenter data collection. [Ann Surg Treat Res 2024;107(6):315-326]
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (5) , 248-254
Outcomes of carotid endarterectomy in octogenarians compared to their younger counterparts: a retrospective observational study
Park JK, et al. Ann Surg Treat Res. 2024 May;106(5):248-254. https://doi.org/10.4174/astr.2024.106.5.248
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (5) , 248-254
Open AccessOutcomes of carotid endarterectomy in octogenarians compared to their younger counterparts: a retrospective observational study
Park JK, et al. Ann Surg Treat Res. 2024 May;106(5):248-254. https://doi.org/10.4174/astr.2024.106.5.248
- 16 February 2023
- Published by SAGE Publications in Vascular
- Vol. 32 (3) , 596-602
The Impact of age and outcomes of high-risk patients on carotid revascularization
Objectives: To validate the accuracy of high-risk criteria for carotid endarterectomy (CEA) and analyze the correlation between age and outcome of CEA and carotid artery stenting (CAS) in risk groups. Methods: We reviewed a prospectively managed vascular surgery database in a single tertiary referral center, and 2482 internal carotid arteries (ICAs) had undergone carotid revascularization from November 1994 to December 2021. To validate high-risk criteria for CEA, patients were classified as high risk (Hr) and normal risk (Nr). Subgroup analysis was performed with patients older or younger than 75 years to investigate the relationship between age and outcome in each group. Primary endpoints were 30-day outcomes including stroke, death, stroke/death, myocardial infraction (MI), and major adverse cardiovascular events (MACEs). Results: A total of 2345 ICAs in 2256 patients were enrolled. The number of patients in the Hr group was 543 (24%) and the number in the Nr group was 1713 (76%). CEA and CAS were performed on 1384 (61%) and 872 (39%) patients, respectively. The 30-day stroke/death rate was higher with CAS than CEA in both the Hr (1.1% vs. 3.9%, p = 0.032) and Nr (1.2% vs. 6.9%, p < 0.001) groups. In unmatched logistic regression analysis of the Nr group ( n = 1778), the rate of 30-day stroke/death (OR, 5.575; 95% CI, 2.922–10.636; p < 0.001) was higher for CAS than CEA. In propensity score matching of the Nr group, the rate of 30-day stroke/death (OR, 5.165; 95% CI, 2.391–11.155; p < 0.001) was also higher for CAS than CEA. In the age <75 subgroup of the Hr group ( n = 428), CAS was associated with higher 30-day stroke/death (OR, 14.089; 95% CI, 1.314–151.036; p = 0.029). In the age ≥75 subgroup of the Hr ( n = 139), there was no difference in 30-day stroke/death between CEA and CAS. In the age <75 subgroup of the Nr group ( n = 1318), 30-day stroke/death (OR, 6.300; 95% CI, 2.797–14.193; p < 0.001) was higher in CAS. In the age ≥75 subgroup of the Nr group ( n = 460), 30-day stroke/death (OR, 6.468; 95% CI, 1.862–22.471; p = 0.003) was higher in CAS. Conclusions: In patients older than 75 years in the Hr group, there were relatively poor 30-day treatment outcomes in both CEA and CAS. Alternative treatment is needed that can expect better outcomes in older high-risk patients. In the Nr group, CEA has a significant benefit compared with CAS, and CEA should be recommended more to these patients.
- 16 February 2023
- Published by SAGE Publications in Vascular
- Vol. 32 (3) , 596-602
The Impact of age and outcomes of high-risk patients on carotid revascularization
Objectives: To validate the accuracy of high-risk criteria for carotid endarterectomy (CEA) and analyze the correlation between age and outcome of CEA and carotid artery stenting (CAS) in risk groups. Methods: We reviewed a prospectively managed vascular surgery database in a single tertiary referral center, and 2482 internal carotid arteries (ICAs) had undergone carotid revascularization from November 1994 to December 2021. To validate high-risk criteria for CEA, patients were classified as high risk (Hr) and normal risk (Nr). Subgroup analysis was performed with patients older or younger than 75 years to investigate the relationship between age and outcome in each group. Primary endpoints were 30-day outcomes including stroke, death, stroke/death, myocardial infraction (MI), and major adverse cardiovascular events (MACEs). Results: A total of 2345 ICAs in 2256 patients were enrolled. The number of patients in the Hr group was 543 (24%) and the number in the Nr group was 1713 (76%). CEA and CAS were performed on 1384 (61%) and 872 (39%) patients, respectively. The 30-day stroke/death rate was higher with CAS than CEA in both the Hr (1.1% vs. 3.9%, p = 0.032) and Nr (1.2% vs. 6.9%, p < 0.001) groups. In unmatched logistic regression analysis of the Nr group ( n = 1778), the rate of 30-day stroke/death (OR, 5.575; 95% CI, 2.922–10.636; p < 0.001) was higher for CAS than CEA. In propensity score matching of the Nr group, the rate of 30-day stroke/death (OR, 5.165; 95% CI, 2.391–11.155; p < 0.001) was also higher for CAS than CEA. In the age <75 subgroup of the Hr group ( n = 428), CAS was associated with higher 30-day stroke/death (OR, 14.089; 95% CI, 1.314–151.036; p = 0.029). In the age ≥75 subgroup of the Hr ( n = 139), there was no difference in 30-day stroke/death between CEA and CAS. In the age <75 subgroup of the Nr group ( n = 1318), 30-day stroke/death (OR, 6.300; 95% CI, 2.797–14.193; p < 0.001) was higher in CAS. In the age ≥75 subgroup of the Nr group ( n = 460), 30-day stroke/death (OR, 6.468; 95% CI, 1.862–22.471; p = 0.003) was higher in CAS. Conclusions: In patients older than 75 years in the Hr group, there were relatively poor 30-day treatment outcomes in both CEA and CAS. Alternative treatment is needed that can expect better outcomes in older high-risk patients. In the Nr group, CEA has a significant benefit compared with CAS, and CEA should be recommended more to these patients.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (47)
Outcomes after Elective Open Abdominal Aortic Aneurysm Repair in Octogenarians Compared to Younger Patients in Korea
Park JK, et al. J Korean Med Sci. 2021 Nov;36(47):e314. https://doi.org/10.3346/jkms.2021.36.e314
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (47)
Open AccessOutcomes after Elective Open Abdominal Aortic Aneurysm Repair in Octogenarians Compared to Younger Patients in Korea
Park JK, et al. J Korean Med Sci. 2021 Nov;36(47):e314. https://doi.org/10.3346/jkms.2021.36.e314